Skip to main content

Advertisement

Contact E. Kedhi

From: Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study

Contact corresponding author